Binx Health
binx health, inc. is a Boston, Massachusetts point-of-care diagnostics company whose binx io platform is the first FDA-cleared, CLIA-waived molecular point-of-care test for chlamydia (Chlamydia trachomatis) and gonorrhea (Neisseria gonorrhoeae), returning central-lab-equivalent results in roughly thirty minutes from female vaginal swabs or male urine so a patient can be tested, diagnosed and treated in a single visit. The instrument pairs ultra-rapid PCR amplification with the company's proprietary electrochemical detection and needs no calibration, preventative maintenance or result interpretation, so it can be run by staff with no laboratory training. binx sells into urgent care, OB/GYN, pediatrics, student health, government health and other specialty settings through distributors including Cardinal Health, McKesson, Medline and Fisher Healthcare. The company divested its at-home consumer testing business to imaware in December 2023 and retained the point-of-care molecular diagnostics business. binx health publishes no public developer program, API reference or machine-readable specification.
Binx Health is profiled on the APIs.io network. Tagged areas include Company, Health, Healthcare, Diagnostics, and Molecular Diagnostics.
Binx Health’s developer surface includes engineering blog, product news, support, and 10 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 1
Properties that don't map to a standard resource type